These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 29356723

  • 1. Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems.
    Verine J, Colin D, Nheb M, Prapotnich D, Ploussard G, Cathelineau X, Desgrandchamps F, Mongiat-Artus P, Feugeas JP.
    Am J Surg Pathol; 2018 Apr; 42(4):423-441. PubMed ID: 29356723
    [Abstract] [Full Text] [Related]

  • 2. Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma.
    Kim H, Inomoto C, Uchida T, Furuya H, Komiyama T, Kajiwara H, Kobayashi H, Nakamura N, Miyajima A.
    Int J Oncol; 2018 Apr; 52(4):1139-1148. PubMed ID: 29532874
    [Abstract] [Full Text] [Related]

  • 3. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP, McKenney JK, Khor LY, Reynolds JP, Magi-Galluzzi C, Przybycin CG.
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [Abstract] [Full Text] [Related]

  • 4. A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis.
    Delahunt B, McKenney JK, Lohse CM, Leibovich BC, Thompson RH, Boorjian SA, Cheville JC.
    Am J Surg Pathol; 2013 Mar; 37(3):311-22. PubMed ID: 23348209
    [Abstract] [Full Text] [Related]

  • 5. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Zigeuner R, Hutterer G, Chromecki T, Imamovic A, Kampel-Kettner K, Rehak P, Langner C, Pummer K.
    Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
    [Abstract] [Full Text] [Related]

  • 6. Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading.
    Dagher J, Delahunt B, Rioux-Leclercq N, Egevad L, Srigley JR, Coughlin G, Dunglinson N, Gianduzzo T, Kua B, Malone G, Martin B, Preston J, Pokorny M, Wood S, Yaxley J, Samaratunga H.
    Histopathology; 2017 Dec; 71(6):918-925. PubMed ID: 28718911
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J, Epstein JI.
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [Abstract] [Full Text] [Related]

  • 8. [The WHO/ISUP grading system for renal carcinoma].
    Moch H.
    Pathologe; 2016 Jul; 37(4):355-60. PubMed ID: 27271258
    [Abstract] [Full Text] [Related]

  • 9. Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma.
    Dagher J, Delahunt B, Rioux-Leclercq N, Egevad L, Coughlin G, Dunglison N, Gianduzzo T, Kua B, Malone G, Martin B, Preston J, Pokorny M, Wood S, Samaratunga H.
    Histopathology; 2019 Jan; 74(2):284-290. PubMed ID: 30129659
    [Abstract] [Full Text] [Related]

  • 10. High WHO/ISUP Grade and Unfavorable Architecture, Rather Than Typing of Papillary Renal Cell Carcinoma, May Be Associated With Worse Prognosis.
    Yang C, Shuch B, Kluger H, Humphrey PA, Adeniran AJ.
    Am J Surg Pathol; 2020 May; 44(5):582-593. PubMed ID: 32101890
    [Abstract] [Full Text] [Related]

  • 11. Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma.
    Parker AS, Eckel-Passow JE, Serie D, Hilton T, Parasramka M, Joseph RW, Wu KJ, Cheville JC, Leibovich BC.
    Eur Urol; 2014 Nov; 66(5):929-35. PubMed ID: 24388441
    [Abstract] [Full Text] [Related]

  • 12. The 'Stage, Size, Grade and Necrosis' score is more accurate than the University of California Los Angeles Integrated Staging System for predicting cancer-specific survival in patients with clear cell renal cell carcinoma.
    Ficarra V, Novara G, Galfano A, Brunelli M, Cavalleri S, Martignoni G, Artibani W.
    BJU Int; 2009 Jan; 103(2):165-70. PubMed ID: 18782313
    [Abstract] [Full Text] [Related]

  • 13. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma.
    Kara O, Maurice MJ, Zargar H, Malkoc E, Akca O, Andrade HS, Ramirez D, Caputo PA, Nelson RJ, Rini B, Kaouk JH.
    Int Urol Nephrol; 2016 Aug; 48(8):1253-1260. PubMed ID: 27215555
    [Abstract] [Full Text] [Related]

  • 14. Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome.
    Cornejo KM, Dong F, Zhou AG, Wu CL, Young RH, Braaten K, Sadow PM, Nielsen GP, Oliva E.
    Hum Pathol; 2015 Oct; 46(10):1411-7. PubMed ID: 26297250
    [Abstract] [Full Text] [Related]

  • 15. Lymphovascular invasion in clear cell renal cell carcinoma--association with disease-free and cancer-specific survival.
    Belsante M, Darwish O, Youssef R, Bagrodia A, Kapur P, Sagalowsky AI, Lotan Y, Margulis V.
    Urol Oncol; 2014 Jan; 32(1):30.e23-8. PubMed ID: 23428539
    [Abstract] [Full Text] [Related]

  • 16. Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--Impact on prognosis.
    Becker A, Hickmann D, Hansen J, Meyer C, Rink M, Schmid M, Eichelberg C, Strini K, Chromecki T, Jesche J, Regier M, Randazzo M, Tilki D, Ahyai S, Dahlem R, Fisch M, Zigeuner R, Chun FK.
    Eur J Surg Oncol; 2016 Mar; 42(3):419-25. PubMed ID: 26520403
    [Abstract] [Full Text] [Related]

  • 17. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S, May M, Shariat SF, Xylinas E, Stief C, Zigeuner R, Chromecki T, Burger M, Wieland WF, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Feciche B, Truss M, Gilfrich C, Pahernik S, Hohenfellner M, Zastrow S, Wirth MP, Novara G, Carini M, Minervini A, Simeone C, Antonelli A, Mirone V, Longo N, Simonato A, Carmignani G, Ficarra V, Members of the CORONA project and the SATURN project.
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [Abstract] [Full Text] [Related]

  • 18. Growth pattern, an important pathologic prognostic parameter for clear cell renal cell carcinoma.
    Fukatsu A, Tsuzuki T, Sassa N, Nishikimi T, Kimura T, Majima T, Yoshino Y, Hattori R, Gotoh M.
    Am J Clin Pathol; 2013 Oct; 140(4):500-5. PubMed ID: 24045546
    [Abstract] [Full Text] [Related]

  • 19. Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.
    Kuthi L, Jenei A, Hajdu A, Németh I, Varga Z, Bajory Z, Pajor L, Iványi B.
    Pathol Oncol Res; 2017 Jul; 23(3):689-698. PubMed ID: 28032311
    [Abstract] [Full Text] [Related]

  • 20. Simplification of the Fuhrman grading system for renal cell carcinoma.
    Smith ZL, Pietzak EJ, Meise CK, Van Arsdalen K, Wein AJ, Malkowicz SB, Guzzo TJ.
    Can J Urol; 2015 Dec; 22(6):8069-73. PubMed ID: 26688135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.